FdaApplication
ANDA 211212
Identifiers
- fda_app_no: ANDA211212
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-10-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIROLIMUS | SIROLIMUS | 1MG/ML | SOLUTION;ORAL |
1 product